Embracing combination treatment pillars in DKD - why, what and how?
This promotional symposium is organised and fully funded by Bayer Plc. It is intended for UK Healthcare professionals only. Bayer products will be discussed at this symposium. Adverse event reporting and prescribing information is available at this session.
Join this interactive symposium with Dr Kevin Fernando and Nadia Malik, where the management of people with chronic kidney disease associated with type 2 diabetes will be brought to life through use of case studies. You will leave the session with an understanding of why it is important to embrace a pillar approach to treatment, what this looks like in practice and how, as a clinician, this can be implemented to improve outcomes for your patients.
RP-KER-GB-0959 Date of Prep August 2024